APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Diagnostics Tests & Reagents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Molecular Diagnostics Tests & Reagents Market Outlook and Growth Opportunities 2026

19 December 2025215 pages

Choose your research edition.

Industry ResearchMolecular Diagnostics Tests & Reagents Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Diagnostics Tests & Reagents Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Molecular Diagnostics Tests & Reagents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Diagnostics Tests & Reagents Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Diagnostics Tests & Reagents Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Molecular Diagnostics Tests & Reagents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Molecular Diagnostics Tests & Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Diagnostics Tests & Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Diagnostics Tests & Reagents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Molecular Diagnostics Tests & Reagents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Molecular Diagnostics Tests & Reagents market include Abbott Laboratories, Shanghai Kehua Bio-engineering, Johnson and Johnson, Merck Millipore, Beijing Leadman Biochemistry, Thermo Scientific, Sysmex Corporation, Siemens Healthcare and Roche Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Molecular Diagnostics Tests & Reagents market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Diagnostics Tests & Reagents and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Diagnostics Tests & Reagents revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Molecular Diagnostics Tests & Reagents market.

Molecular Diagnostics Tests & Reagents Segment by Company

Abbott Laboratories

Shanghai Kehua Bio-engineering

Johnson and Johnson

Merck Millipore

Beijing Leadman Biochemistry

Thermo Scientific

Sysmex Corporation

Siemens Healthcare

Roche Diagnostics

Ortho Clinical Diagnostics

Mindray

Danaher Corporation

DAAN Gene

Cobas

Caprion

BioSino Bio-technology

Bio-Rad Laboratories

Biomerieux

Becton Dickinson

Beckman Coulter Inc

Aptiv Solution

Molecular Diagnostics Tests & Reagents Segment by Type

Professional Diagnostic

Diabetes Monitoring

Molecular Diagnostic

Molecular Diagnostics Tests & Reagents Segment by Application

HIV

Infectious Diseases

Diabetes

Cardiology

Oncology

Other

Molecular Diagnostics Tests & Reagents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Molecular Diagnostics Tests & Reagents status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Molecular Diagnostics Tests & Reagents key companies, revenue, market share, and recent developments.

3. To split the Molecular Diagnostics Tests & Reagents breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Molecular Diagnostics Tests & Reagents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molecular Diagnostics Tests & Reagents significant trends, drivers, influence factors in global and regions.

6. To analyze Molecular Diagnostics Tests & Reagents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostics Tests & Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostics Tests & Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostics Tests & Reagents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Diagnostics Tests & Reagents industry.

Chapter 3: Detailed analysis of Molecular Diagnostics Tests & Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Molecular Diagnostics Tests & Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Molecular Diagnostics Tests & Reagents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molecular Diagnostics Tests & Reagents Industry Trends Table 2. Molecular Diagnostics Tests & Reagents Industry Drivers Table 3. Molecular Diagnostics Tests & Reagents Industry Opportunities and Challenges Table 4. Molecular Diagnostics Tests & Reagents Industry Restraints Table 5. Global Molecular Diagnostics Tests & Reagents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molecular Diagnostics Tests & Reagents Revenue Share by Company (2021-2026) Table 7. Global Molecular Diagnostics Tests & Reagents Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Molecular Diagnostics Tests & Reagents Key Company Manufacturing Base & Headquarters Table 9. Global Molecular Diagnostics Tests & Reagents Company, Product Type & Application Table 10. Global Molecular Diagnostics Tests & Reagents Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Molecular Diagnostics Tests & Reagents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Professional Diagnostic Table 15. Significant Companies of Diabetes Monitoring Table 16. Significant Companies of Molecular Diagnostic Table 17. Global Molecular Diagnostics Tests & Reagents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Molecular Diagnostics Tests & Reagents Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Molecular Diagnostics Tests & Reagents Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Type (2021-2026) Table 21. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Type (2027-2032) Table 22. Significant Companies of HIV Table 23. Significant Companies of Infectious Diseases Table 24. Significant Companies of Diabetes Table 25. Significant Companies of Cardiology Table 26. Significant Companies of Oncology Table 27. Significant Companies of Other Table 28. Global Molecular Diagnostics Tests & Reagents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Molecular Diagnostics Tests & Reagents Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Molecular Diagnostics Tests & Reagents Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Application (2021-2026) Table 32. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Application (2027-2032) Table 33. Global Molecular Diagnostics Tests & Reagents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Molecular Diagnostics Tests & Reagents Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Region (2021-2026) Table 36. Global Molecular Diagnostics Tests & Reagents Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Region (2027-2032) Table 38. Global Molecular Diagnostics Tests & Reagents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Molecular Diagnostics Tests & Reagents Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Molecular Diagnostics Tests & Reagents Sales Value Market Share by Country (2021-2026) Table 41. Global Molecular Diagnostics Tests & Reagents Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Molecular Diagnostics Tests & Reagents Sales Value Market Share by Country (2027-2032) Table 43. Abbott Laboratories Company Information Table 44. Abbott Laboratories Business Overview Table 45. Abbott Laboratories Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Abbott Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio Table 47. Abbott Laboratories Recent Development Table 48. Shanghai Kehua Bio-engineering Company Information Table 49. Shanghai Kehua Bio-engineering Business Overview Table 50. Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Product Portfolio Table 52. Shanghai Kehua Bio-engineering Recent Development Table 53. Johnson and Johnson Company Information Table 54. Johnson and Johnson Business Overview Table 55. Johnson and Johnson Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Johnson and Johnson Molecular Diagnostics Tests & Reagents Product Portfolio Table 57. Johnson and Johnson Recent Development Table 58. Merck Millipore Company Information Table 59. Merck Millipore Business Overview Table 60. Merck Millipore Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Merck Millipore Molecular Diagnostics Tests & Reagents Product Portfolio Table 62. Merck Millipore Recent Development Table 63. Beijing Leadman Biochemistry Company Information Table 64. Beijing Leadman Biochemistry Business Overview Table 65. Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Product Portfolio Table 67. Beijing Leadman Biochemistry Recent Development Table 68. Thermo Scientific Company Information Table 69. Thermo Scientific Business Overview Table 70. Thermo Scientific Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Thermo Scientific Molecular Diagnostics Tests & Reagents Product Portfolio Table 72. Thermo Scientific Recent Development Table 73. Sysmex Corporation Company Information Table 74. Sysmex Corporation Business Overview Table 75. Sysmex Corporation Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sysmex Corporation Molecular Diagnostics Tests & Reagents Product Portfolio Table 77. Sysmex Corporation Recent Development Table 78. Siemens Healthcare Company Information Table 79. Siemens Healthcare Business Overview Table 80. Siemens Healthcare Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Siemens Healthcare Molecular Diagnostics Tests & Reagents Product Portfolio Table 82. Siemens Healthcare Recent Development Table 83. Roche Diagnostics Company Information Table 84. Roche Diagnostics Business Overview Table 85. Roche Diagnostics Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Roche Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio Table 87. Roche Diagnostics Recent Development Table 88. Ortho Clinical Diagnostics Company Information Table 89. Ortho Clinical Diagnostics Business Overview Table 90. Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio Table 92. Ortho Clinical Diagnostics Recent Development Table 93. Mindray Company Information Table 94. Mindray Business Overview Table 95. Mindray Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Mindray Molecular Diagnostics Tests & Reagents Product Portfolio Table 97. Mindray Recent Development Table 98. Danaher Corporation Company Information Table 99. Danaher Corporation Business Overview Table 100. Danaher Corporation Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Danaher Corporation Molecular Diagnostics Tests & Reagents Product Portfolio Table 102. Danaher Corporation Recent Development Table 103. DAAN Gene Company Information Table 104. DAAN Gene Business Overview Table 105. DAAN Gene Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. DAAN Gene Molecular Diagnostics Tests & Reagents Product Portfolio Table 107. DAAN Gene Recent Development Table 108. Cobas Company Information Table 109. Cobas Business Overview Table 110. Cobas Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Cobas Molecular Diagnostics Tests & Reagents Product Portfolio Table 112. Cobas Recent Development Table 113. Caprion Company Information Table 114. Caprion Business Overview Table 115. Caprion Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Caprion Molecular Diagnostics Tests & Reagents Product Portfolio Table 117. Caprion Recent Development Table 118. BioSino Bio-technology Company Information Table 119. BioSino Bio-technology Business Overview Table 120. BioSino Bio-technology Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. BioSino Bio-technology Molecular Diagnostics Tests & Reagents Product Portfolio Table 122. BioSino Bio-technology Recent Development Table 123. Bio-Rad Laboratories Company Information Table 124. Bio-Rad Laboratories Business Overview Table 125. Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio Table 127. Bio-Rad Laboratories Recent Development Table 128. Biomerieux Company Information Table 129. Biomerieux Business Overview Table 130. Biomerieux Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Biomerieux Molecular Diagnostics Tests & Reagents Product Portfolio Table 132. Biomerieux Recent Development Table 133. Becton Dickinson Company Information Table 134. Becton Dickinson Business Overview Table 135. Becton Dickinson Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Becton Dickinson Molecular Diagnostics Tests & Reagents Product Portfolio Table 137. Becton Dickinson Recent Development Table 138. Beckman Coulter Inc Company Information Table 139. Beckman Coulter Inc Business Overview Table 140. Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Product Portfolio Table 142. Beckman Coulter Inc Recent Development Table 143. Aptiv Solution Company Information Table 144. Aptiv Solution Business Overview Table 145. Aptiv Solution Molecular Diagnostics Tests & Reagents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Aptiv Solution Molecular Diagnostics Tests & Reagents Product Portfolio Table 147. Aptiv Solution Recent Development Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Molecular Diagnostics Tests & Reagents Product Image Figure 2. Global Molecular Diagnostics Tests & Reagents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Diagnostics Tests & Reagents Market Size (2021-2032) & (US$ Million) Figure 4. Global Molecular Diagnostics Tests & Reagents Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Professional Diagnostic Image Figure 8. Diabetes Monitoring Image Figure 9. Molecular Diagnostic Image Figure 10. Global Molecular Diagnostics Tests & Reagents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Molecular Diagnostics Tests & Reagents Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Type (2021-2032) Figure 13. HIV Image Figure 14. Infectious Diseases Image Figure 15. Diabetes Image Figure 16. Cardiology Image Figure 17. Oncology Image Figure 18. Other Image Figure 19. Global Molecular Diagnostics Tests & Reagents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Molecular Diagnostics Tests & Reagents Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Application (2021-2032) Figure 22. Global Molecular Diagnostics Tests & Reagents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Molecular Diagnostics Tests & Reagents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Molecular Diagnostics Tests & Reagents Sales Value (2021-2032) & (US$ Million) Figure 25. North America Molecular Diagnostics Tests & Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Molecular Diagnostics Tests & Reagents Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Molecular Diagnostics Tests & Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Molecular Diagnostics Tests & Reagents Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Molecular Diagnostics Tests & Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Molecular Diagnostics Tests & Reagents Sales Value (2021-2032) & (US$ Million) Figure 31. South America Molecular Diagnostics Tests & Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Molecular Diagnostics Tests & Reagents Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Molecular Diagnostics Tests & Reagents Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Professional Diagnostic
  • Diabetes Monitoring
  • Molecular Diagnostic
Applications
  • HIV
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Other
Companies covered
  • Abbott Laboratories
  • Shanghai Kehua Bio-engineering
  • Johnson and Johnson
  • Merck Millipore
  • Beijing Leadman Biochemistry
  • Thermo Scientific
  • Sysmex Corporation
  • Siemens Healthcare
  • Roche Diagnostics
  • Ortho Clinical Diagnostics
  • Mindray
  • Danaher Corporation
  • DAAN Gene
  • Cobas
  • Caprion
  • BioSino Bio-technology
  • Bio-Rad Laboratories
  • Biomerieux
  • Becton Dickinson
  • Beckman Coulter Inc
  • Aptiv Solution

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Molecular Diagnostics Tests & Reagents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Molecular Diagnostics Tests & Reagents Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Molecular Diagnostics Tests & Reagents Market Dynamics
  1. 2.1 Molecular Diagnostics Tests & Reagents Industry Trends
  2. 2.2 Molecular Diagnostics Tests & Reagents Industry Drivers
  3. 2.3 Molecular Diagnostics Tests & Reagents Industry Opportunities and Challenges
  4. 2.4 Molecular Diagnostics Tests & Reagents Industry Restraints
3 Molecular Diagnostics Tests & Reagents Market by Company
  1. 3.1 Global Molecular Diagnostics Tests & Reagents Company Revenue Ranking in 2025
  2. 3.2 Global Molecular Diagnostics Tests & Reagents Revenue by Company (2021-2026)
  3. 3.3 Global Molecular Diagnostics Tests & Reagents Company Ranking (2024-2026)
  4. 3.4 Global Molecular Diagnostics Tests & Reagents Company Manufacturing Base and Headquarters
  5. 3.5 Global Molecular Diagnostics Tests & Reagents Company Product Type and Application
  6. 3.6 Global Molecular Diagnostics Tests & Reagents Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Molecular Diagnostics Tests & Reagents Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Molecular Diagnostics Tests & Reagents Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Molecular Diagnostics Tests & Reagents Market by Type
  1. 4.1 Molecular Diagnostics Tests & Reagents Type Introduction
  2. 4.1.1 Professional Diagnostic
  3. 4.1.2 Diabetes Monitoring
  4. 4.1.3 Molecular Diagnostic
  5. 4.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Type
  6. 4.2.1 Global Molecular Diagnostics Tests & Reagents Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Type (2021-2032)
  8. 4.2.3 Global Molecular Diagnostics Tests & Reagents Sales Value Share by Type (2021-2032)
5 Molecular Diagnostics Tests & Reagents Market by Application
  1. 5.1 Molecular Diagnostics Tests & Reagents Application Introduction
  2. 5.1.1 HIV
  3. 5.1.2 Infectious Diseases
  4. 5.1.3 Diabetes
  5. 5.1.4 Cardiology
  6. 5.1.5 Oncology
  7. 5.1.6 Other
  8. 5.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Application
  9. 5.2.1 Global Molecular Diagnostics Tests & Reagents Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Application (2021-2032)
  11. 5.2.3 Global Molecular Diagnostics Tests & Reagents Sales Value Share by Application (2021-2032)
6 Molecular Diagnostics Tests & Reagents Regional Value Analysis
  1. 6.1 Global Molecular Diagnostics Tests & Reagents Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Region (2021-2032)
  3. 6.2.1 Global Molecular Diagnostics Tests & Reagents Sales Value by Region: 2021-2026
  4. 6.2.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Molecular Diagnostics Tests & Reagents Sales Value (2021-2032)
  7. 6.3.2 North America Molecular Diagnostics Tests & Reagents Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Molecular Diagnostics Tests & Reagents Sales Value (2021-2032)
  10. 6.4.2 Europe Molecular Diagnostics Tests & Reagents Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Molecular Diagnostics Tests & Reagents Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Molecular Diagnostics Tests & Reagents Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Molecular Diagnostics Tests & Reagents Sales Value (2021-2032)
  16. 6.6.2 South America Molecular Diagnostics Tests & Reagents Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Molecular Diagnostics Tests & Reagents Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Molecular Diagnostics Tests & Reagents Sales Value Share by Country, 2025 VS 2032
7 Molecular Diagnostics Tests & Reagents Country-level Value Analysis
  1. 7.1 Global Molecular Diagnostics Tests & Reagents Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Country (2021-2032)
  3. 7.2.1 Global Molecular Diagnostics Tests & Reagents Sales Value by Country (2021-2026)
  4. 7.2.2 Global Molecular Diagnostics Tests & Reagents Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Molecular Diagnostics Tests & Reagents Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Molecular Diagnostics Tests & Reagents Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Molecular Diagnostics Tests & Reagents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Shanghai Kehua Bio-engineering
  8. 8.2.1 Shanghai Kehua Bio-engineering Company Information
  9. 8.2.2 Shanghai Kehua Bio-engineering Business Overview
  10. 8.2.3 Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Kehua Bio-engineering Molecular Diagnostics Tests & Reagents Product Portfolio
  12. 8.2.5 Shanghai Kehua Bio-engineering Recent Developments
  13. 8.3 Johnson and Johnson
  14. 8.3.1 Johnson and Johnson Company Information
  15. 8.3.2 Johnson and Johnson Business Overview
  16. 8.3.3 Johnson and Johnson Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson and Johnson Molecular Diagnostics Tests & Reagents Product Portfolio
  18. 8.3.5 Johnson and Johnson Recent Developments
  19. 8.4 Merck Millipore
  20. 8.4.1 Merck Millipore Company Information
  21. 8.4.2 Merck Millipore Business Overview
  22. 8.4.3 Merck Millipore Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Millipore Molecular Diagnostics Tests & Reagents Product Portfolio
  24. 8.4.5 Merck Millipore Recent Developments
  25. 8.5 Beijing Leadman Biochemistry
  26. 8.5.1 Beijing Leadman Biochemistry Company Information
  27. 8.5.2 Beijing Leadman Biochemistry Business Overview
  28. 8.5.3 Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Leadman Biochemistry Molecular Diagnostics Tests & Reagents Product Portfolio
  30. 8.5.5 Beijing Leadman Biochemistry Recent Developments
  31. 8.6 Thermo Scientific
  32. 8.6.1 Thermo Scientific Company Information
  33. 8.6.2 Thermo Scientific Business Overview
  34. 8.6.3 Thermo Scientific Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Scientific Molecular Diagnostics Tests & Reagents Product Portfolio
  36. 8.6.5 Thermo Scientific Recent Developments
  37. 8.7 Sysmex Corporation
  38. 8.7.1 Sysmex Corporation Company Information
  39. 8.7.2 Sysmex Corporation Business Overview
  40. 8.7.3 Sysmex Corporation Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sysmex Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
  42. 8.7.5 Sysmex Corporation Recent Developments
  43. 8.8 Siemens Healthcare
  44. 8.8.1 Siemens Healthcare Company Information
  45. 8.8.2 Siemens Healthcare Business Overview
  46. 8.8.3 Siemens Healthcare Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Siemens Healthcare Molecular Diagnostics Tests & Reagents Product Portfolio
  48. 8.8.5 Siemens Healthcare Recent Developments
  49. 8.9 Roche Diagnostics
  50. 8.9.1 Roche Diagnostics Company Information
  51. 8.9.2 Roche Diagnostics Business Overview
  52. 8.9.3 Roche Diagnostics Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Roche Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
  54. 8.9.5 Roche Diagnostics Recent Developments
  55. 8.10 Ortho Clinical Diagnostics
  56. 8.10.1 Ortho Clinical Diagnostics Company Information
  57. 8.10.2 Ortho Clinical Diagnostics Business Overview
  58. 8.10.3 Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ortho Clinical Diagnostics Molecular Diagnostics Tests & Reagents Product Portfolio
  60. 8.10.5 Ortho Clinical Diagnostics Recent Developments
  61. 8.11 Mindray
  62. 8.11.1 Mindray Company Information
  63. 8.11.2 Mindray Business Overview
  64. 8.11.3 Mindray Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mindray Molecular Diagnostics Tests & Reagents Product Portfolio
  66. 8.11.5 Mindray Recent Developments
  67. 8.12 Danaher Corporation
  68. 8.12.1 Danaher Corporation Company Information
  69. 8.12.2 Danaher Corporation Business Overview
  70. 8.12.3 Danaher Corporation Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Danaher Corporation Molecular Diagnostics Tests & Reagents Product Portfolio
  72. 8.12.5 Danaher Corporation Recent Developments
  73. 8.13 DAAN Gene
  74. 8.13.1 DAAN Gene Company Information
  75. 8.13.2 DAAN Gene Business Overview
  76. 8.13.3 DAAN Gene Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DAAN Gene Molecular Diagnostics Tests & Reagents Product Portfolio
  78. 8.13.5 DAAN Gene Recent Developments
  79. 8.14 Cobas
  80. 8.14.1 Cobas Company Information
  81. 8.14.2 Cobas Business Overview
  82. 8.14.3 Cobas Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cobas Molecular Diagnostics Tests & Reagents Product Portfolio
  84. 8.14.5 Cobas Recent Developments
  85. 8.15 Caprion
  86. 8.15.1 Caprion Company Information
  87. 8.15.2 Caprion Business Overview
  88. 8.15.3 Caprion Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Caprion Molecular Diagnostics Tests & Reagents Product Portfolio
  90. 8.15.5 Caprion Recent Developments
  91. 8.16 BioSino Bio-technology
  92. 8.16.1 BioSino Bio-technology Company Information
  93. 8.16.2 BioSino Bio-technology Business Overview
  94. 8.16.3 BioSino Bio-technology Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BioSino Bio-technology Molecular Diagnostics Tests & Reagents Product Portfolio
  96. 8.16.5 BioSino Bio-technology Recent Developments
  97. 8.17 Bio-Rad Laboratories
  98. 8.17.1 Bio-Rad Laboratories Company Information
  99. 8.17.2 Bio-Rad Laboratories Business Overview
  100. 8.17.3 Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bio-Rad Laboratories Molecular Diagnostics Tests & Reagents Product Portfolio
  102. 8.17.5 Bio-Rad Laboratories Recent Developments
  103. 8.18 Biomerieux
  104. 8.18.1 Biomerieux Company Information
  105. 8.18.2 Biomerieux Business Overview
  106. 8.18.3 Biomerieux Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Biomerieux Molecular Diagnostics Tests & Reagents Product Portfolio
  108. 8.18.5 Biomerieux Recent Developments
  109. 8.19 Becton Dickinson
  110. 8.19.1 Becton Dickinson Company Information
  111. 8.19.2 Becton Dickinson Business Overview
  112. 8.19.3 Becton Dickinson Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Becton Dickinson Molecular Diagnostics Tests & Reagents Product Portfolio
  114. 8.19.5 Becton Dickinson Recent Developments
  115. 8.20 Beckman Coulter Inc
  116. 8.20.1 Beckman Coulter Inc Company Information
  117. 8.20.2 Beckman Coulter Inc Business Overview
  118. 8.20.3 Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Beckman Coulter Inc Molecular Diagnostics Tests & Reagents Product Portfolio
  120. 8.20.5 Beckman Coulter Inc Recent Developments
  121. 8.21 Aptiv Solution
  122. 8.21.1 Aptiv Solution Company Information
  123. 8.21.2 Aptiv Solution Business Overview
  124. 8.21.3 Aptiv Solution Molecular Diagnostics Tests & Reagents Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Aptiv Solution Molecular Diagnostics Tests & Reagents Product Portfolio
  126. 8.21.5 Aptiv Solution Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst